FDA Warning Letter — Tubilux Pharma Spa
The FDA took a Warning Letter action against Tubilux Pharma Spa on July 6, 2017 (Pomezia, Italy). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- Tubilux Pharma Spa
- Date
- July 6, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Pomezia (Italy)